Guowen Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
Papers in
-
- RNA modifications and cancer 9
- Circular RNAs in diseases 5
-
- Ferroptosis and cancer prognosis 9
- Sarcoma Diagnosis and Treatment 5
- Co-authors
- Shunbin Xiong (5 shared papers)Tianyang Mu (5 shared papers)Xuejun Jiang (1 shared paper)Jilong Yang (9 shared papers)Xiaoling Du (4 shared papers)Xiuxin Han (16 shared papers)Kexin Chen (6 shared papers)Chuankui Li (5 shared papers)
- Journals
- Frontiers in Immunology (6 papers)BMC Genomics (5 papers)Aging (3 papers)Journal of Clinical Oncology (3 papers)Theriogenology (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Guowen Wang
88 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 400
- Oncology 323
- Molecular Biology 847
- Pulmonary and Respiratory Medicine 293
- Immunology 152
Countries citing papers authored by Guowen Wang
This map shows the geographic impact of Guowen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guowen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guowen Wang more than expected).
Fields of papers citing papers by Guowen Wang
This network shows the impact of papers produced by Guowen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guowen Wang. The network helps show where Guowen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guowen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 339 | |
| 2 | Advances in targeted therapy for osteosarcoma. | 2014 | 117 |
| 3 | 2018 | 110 | |
| 4 | 2006 | 88 | |
| 5 | 2023 | 73 | |
| 6 | 2020 | 63 | |
| 7 | 2023 | 58 | |
| 8 | 2016 | 51 | |
| 9 | 2021 | 50 | |
| 10 | 2015 | 48 | |
| 11 | 2013 | 46 | |
| 12 | 2021 | 44 | |
| 13 | 2020 | 41 | |
| 14 | 2015 | 39 | |
| 15 | 2020 | 36 | |
| 16 | 2023 | 35 | |
| 17 | 2015 | 32 | |
| 18 | 2013 | 29 | |
| 19 | 2013 | 27 | |
| 20 | 2020 | 24 |
About Guowen Wang
Guowen Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Ferroptosis and cancer prognosis (9 papers), RNA modifications and cancer (9 papers), Management of metastatic bone disease (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (5 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Cancer Research (400 citations), Oncology (323 citations), Molecular Biology (847 citations), Pulmonary and Respiratory Medicine (293 citations) and Immunology (152 citations). Guowen Wang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Shunbin Xiong, Tianyang Mu, Xuejun Jiang, Jilong Yang, Xiaoling Du, Xiuxin Han, Kexin Chen, Chuankui Li, Jinyan Feng and Wenxia Zhou. Their work appears in journals such as Frontiers in Immunology, BMC Genomics, Aging, Journal of Clinical Oncology and Theriogenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.